RGEBX
Price
$82.32
Change
+$0.51 (+0.62%)
Updated
Aug 28 closing price
Net Assets
327.53B
TWUAX
Price
$92.04
Change
+$0.55 (+0.60%)
Updated
Aug 28 closing price
Net Assets
26.16B
Interact to see
Advertisement

RGEBX vs TWUAX

Header iconRGEBX vs TWUAX Comparison
Open Charts RGEBX vs TWUAXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$82.32
Change+$0.51 (+0.62%)
VolumeN/A
Net Assets327.53B
American Century Ultra® A
Price$92.04
Change+$0.55 (+0.60%)
VolumeN/A
Net Assets26.16B
RGEBX vs TWUAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGEBX vs. TWUAX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and TWUAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 328B vs. TWUAX (26.2B). RGEBX (0.00) and TWUAX (0.00) have matching dividends . RGEBX was incepted earlier than TWUAX: RGEBX (11 years) vs TWUAX (29 years). TWUAX (1.17) is less costly to investors than RGEBX (1.09). RGEBX is a more actively managed with annual turnover of: 25.00 vs. TWUAX (7.00). RGEBX has a lower initial minimum investment than TWUAX: RGEBX (250) vs TWUAX (2500). RGEBX annual gain was more profitable for investors over the last year : 14.97 vs. TWUAX (11.41). RGEBX (34.49) and TWUAX (33.13) have equivalent 5 years return.
RGEBXTWUAXRGEBX / TWUAX
Total Expense Ratio1.091.1297%
Annual Report Gross Expense Ratio1.091.1793%
Fund Existence11 years29 years-
Gain YTD15.2306.657229%
Front LoadN/A6%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets328B26.2B1,252%
Annual Yield % from dividends0.000.00-
Returns for 1 year14.9711.41131%
Returns for 3 years52.2446.90111%
Returns for 5 years34.4933.13104%
Returns for 10 years91.38165.2655%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HNDL21.940.07
+0.30%
Strategy Shares Nasdaq 7 Handl™ ETF
MCDS57.75N/A
N/A
JPMorgan Fundamental Data Sci Md Cor ETF
THTA15.01-0.01
-0.06%
SoFi Enhanced Yield ETF
XPH47.26-0.04
-0.08%
SPDR® S&P Pharmaceuticals ETF
DFAT58.83-0.10
-0.17%
Dimensional US Targeted Value ETF